Prestige closes Breathe Right acquisition for $1B
Share
- Prestige Consumer Healthcare closed its acquisition of the Breathe Right brand.
- The company completed the $1.045 billion transaction using cash and debt.
- The acquisition expands the company's product portfolio into a new category.
Prestige Consumer Healthcare (NYSE:PBH) closed its acquisition of the Breathe Right brand for $1.045 billion.
This closing completes an asset purchase agreement originally announced on March 20, 2026.
The net cost is approximately $900 million after deducting $150 million in anticipated tax benefits.
Prestige financed the brand transaction through available cash and a new Term Loan B.
Following the announcement, Prestige Consumer Healthcare's share price was down at $46.67.
Breathe Right was created in the 1990s within the nasal strip category.
The company stated that the brand will become its largest product line.
